ScholarWorks@Gyeongsang National University: Kang, Ki Mun

Detailed Information

Kang, Ki Mun (강기문)

의과대학 (의학과)

Research Area

Tel 0552143217
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

radiotherapy:8||Radiotherapy:8||Breast cancer:6||Brain metastasis:5||Overall survival:5||Cisplatin:4||radiation therapy:4||stereotactic body radiotherapy:4||Wholebrain radiotherapy:3||Monte Carlo:3||Head and neck neoplasms:3||chemoradiotherapy:3||Chemoradiotherapy:3||lung cancer:3||lymphocyte:2||lymphocytes:2||Fourdimensional radiation treatment plan:2||Brachytherapy:2||tissue heterogeneity:2||Neck lymph nodes:2||triplenegative breast cancer:2||mebendazole:2||Lung cancer:2||Breast neoplasms:2||Recombinant human epidermal growth factor:2||nonsmall cell lung cancer:2||Concurrent chemoradiotherapy:2||Rectal cancer:2||oxidative stress:2||alpha lipoic acid:2||방사선치료:2||Oral mucositis:2||식도암:2||prognosis:2||hepatocellular carcinoma:2||radiation:2||Esophageal cancer:2||Robotic radiotherapy:2||radiation pneumonitis:2||Irradiation:2||Brain tumor:2||Patterns of care study:2||inflammation:2||Hypofractionated radiotherapy:2||Planning target volume:2||breast neoplasms:2||Mice:2||cancer stem cell:2||Monte Carlo algorithm:2||salivary gland:2||Intrafraction Tumor Motion:1||Intrafraction movement:1||Intrafractionation movement:1||Key Words:1||Ki67:1||Laryngeal cancer:1||Local control:1||Locally advanced:1||Lung metastasis:1||Lung neoplasm:1||Lymphoma:1||Lymphovascular invasion:1||MGMT protein:1||MRIbased radiotherapy:1||Machine Vision:1||Mesorectal excision:1||Metaanalysis:1||Methotrexate:1||Mucositis:1||NFkappa B:1||NK cells:1||Neoplasm:1||Nonsmall cell lung cancer:1||Nonsmallcell lung carcinoma:1||Nox2:1||Old age:1||Organ weight:1||PCS:1||Palliation:1||Pattern of care study:1||Patterns of care:1||Perineural invasion:1||Prognosis:1||Prognostic model:1||Prostate Cancer:1||Prostate Neoplasms:1||ProstateSpecific Antigen:1||RTQA:1||Radiationinduced hepatic toxicity (RIHT):1||Radioprotection:1||Radiosurgery:1||Radiotherapy Planning:1||Recombinant human epidermal growth factor (rhEGF):1||Rectum:1||Recurrence:1||Recursive partitioning analysis:1||Resection margin:1||Respiration Guiding:1||RespiratoryGated Radiation Therapy:1||SBRT:1||Salvage therapy:1||Salvage treatment:1||Senescence:1||Small cell lung carcinoma:1||Staging:1||Stereotactic Body Radiation Therapy:1||Stereotactic Body Radiotherapy:1||Stereotactic body radiotherapy (SBRT):1||Stereotactic radiosurgery:1||Survival rate:1||TNFalpha:1||Tumor molecular subtype:1||Unresectable pancreatic cancer:1||Vitamin E:1||Wait and see:1||Whole brain radiotherapy:1||abscopal effect:1||adhesion molecules:1||alphalipoic acid:1||anthelmintic:1||antitumor activity:1||antioxidant effect:1||antitumor effect:1||baseline shifts:1||benzimidazole:1||betaglucan:1||bisacurone:1||brain metastases:1||brain radiosurgery:1||brain tumor:1||c mice:1||calculation algorithm:1||carbonic anhydrase IX:1||chemotherapy resistance:1||cognitive disorder:1||complication:1||complications:1||concurrent chemoradiotherapy:1||cytokine:1||diseasefree survival:1||dosevolume constraint:1||effective path length correction:1||elderly:1||epithelialmesenchymal transition:1||esophageal neoplasms:1||fieldspecific proton margin:1||fourdimensional computed tomography:1||fourdimensional proton plan:1||frameless radiosurgery:1||geometric error:1||glucose transporter1:1||hydrogen water:1||hypoxiainducible factor1:1||immune checkpoint inhibitor:1||immuneresponse:1||immunosuppression:1||inflammatory disease:1||intensitymodulated radiation therapy:1||intensitymodulated radiotherapy:1||intrafraction movement:1||invasiveness:1||laryngeal carcinoma:1||liver neoplasms:1||loss of heterozygosity:1||magnesium stick:1||malignant airway obstruction:1||mannose 6phosphate/insulinlike growth factor 2 receptor:1||margin:1||metastasectomy:1||metastasis:1||natural killer cell:1||neutrophil:1||neutrophiltolymphocyte ratio:1||oral mucosa:1||oropharyngeal cancer:1||overall survival:1||palliative:1||parasympathetic innervation:1||patterns of failure:1||platelettolymphocyte ratio:1||portal vein:1||prognostic factors:1||proton therapy:1||pulmonary metastases:1||radiation dose:1||radiationinduced liver disease:1||radioresistance:1||radioresistant breast cancer cells:1||radiosurgery:1||radiotherapy planning:1||ray tracing:1||reactive oxygen species:1||rectal neoplasm:1||respiration motion:1||respiratorygated radiotherapy:1||rigid image registration:1||sarcopenia:1||senescence:1||small intestine:1||stereotactic radiosurgery:1||stomach:1||survival:1||target volume:1||treatment time:1||tumor:1||tumor volume:1||variation:1||vascular cell adhesion molecule1:1||xerostomia:1||고령:1||구내염:1||뇌종양:1||동시 항암화학방사선치료:1||마우스이 논문은 2007년 11월 7일 접수하여 2007년 11월 29일 채택되었음.:1||몬테칼로 알고리즘:1||무고정틀 방사선수술:1||방사선조사:1||사차원방사선치료계획:1||정위적 방사선 수술:1||종양추적 정위방사선치료:1||치료방법:1||치료중 움직임:1||폐암:1||3D Imaging:1||후두암:1||Adjuvant chemotherapy:1||Adjuvant radiotherapy:1||Alpha lipoic acid:1||Alphalipoic acid:1||Antioxidative potential:1||Autocontouring:1||BALB:1||Bile duct neoplasms:1||Biomarkers:1||Blood biochemistry:1||Body weight:1||Braindirected treatment:1||CD4(+):1||CD8(+):1||Central nervous system:1||Cervical Cancer:1||Cervical cancer:1||Chemotherapy:1||ChildPugh class (CP class):1||ChildPugh score:1||Colorectal neoplasms:1||Concurrent chemoand radiotherapy (CCRT):1||CyberKnife:1||Cyberknife:1||Cyberknife Radiosurgery:1||Deep learning:1||Dose toxicity study:1||Early glottic cancer:1||Elderly patients:1||Enterococcus Faecalis 2001:1||Enterococcus faecalis:1||Epidermal growth factor:1||Esophageal carcinoma:1||Fraction size:1||Frameless radiosurgery:1||Glottic carcinoma:1||Grade:1||Head and neck cancer:1||Hepatocellular carcinoma:1||Hepatocellular carcinoma (HCC):1||Hif1 alpha:1||Histology:1||Hypofractionation:1||IFNgamma:1||Imageguided:1||Immunity:1||Inflammatory breast cancer:1||Intensitymodulated radiotherapy:1||Interobserver variation:1||

STATISTICS: Total View :5,632,514; Today View :10,656

RSS_1.0 RSS_2.0 ATOM_1.0

Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0533

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE